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Toscana virus (TOSV) has recently been recognized as an emerging virus transmitted by phlebotomus vectors, responsible for acute
neurological diseases in Mediterranean countries. In our study, we demonstrated that adult Balb/c mice were susceptible to TOSV when
infected intracerebrally (ic.) or subcutaneously (sc.) with a neuroadapted strain of the virus. We have shown that by performing serial
passages of a wild type human isolate of TOSV in mouse brains, selection occurs for a highly virulent variant which replicates efficiently in
the central nervous system (CNS) of ic.-injected mice, causing acute encephalitis and death. Immunohistochemical analysis and TUNEL
assay of post-mortem organs showed that TOSV replication was highly restricted to neurons in which it induced apoptotic death; however,
virus antigen-positivity was also observed in the spleen and lymph nodes. In sc.-injected mice, virus was detectable in the spleen and lymph
nodes, whereas only few meningeal cells and neurons were affected, allowing for the mouse survival the infection. The presence of TOSV in
spleen and lymph node cells in both sc.- and ic.-treated mice suggests their possible involvement in the diffusion of the infection. This animal
model may be helpful for the development of prophylactic measures against TOSV infections.
D 2004 Elsevier Inc. All rights reserved.
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The Bunyaviridae family consists almost entirely of
viruses transmitted to vertebrate animals by arthropods
(American Committee on Arthropod-Borne Viruses, 1985).
It includes the Phlebovirus genus which is composed of 38
serologically distinct viruses (Tesh, 1988; Verani et al.,
1980). Among these, Toscana virus (TOSV) was first
isolated from Phlebotomus perniciosus sand flies in Italy
in 1971 and subsequently and repeatedly isolated from P.
perniciosus and P. perfiliewi.(Braito et al., 1998; Verani et
al., 1980, 1982). Toscana virus is an enveloped virion with a
segmented negative-strand RNA genome consisting of three0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: cusi@unisi.it (M. Grazia Cusi).noncovalently closed, circular RNA fragments, (Large,
Medium and Small). These code for the large protein, the
envelope glycoproteins (G1 and G2), the nucleocapsid
protein and the non-structural proteins, respectively
(Accardi et al., 1993; Bishop, 1990; Di Bonito et al.,
1997). Toscana virus is endemic in the Mediterranean
countries where phlebotomus vectors are present. Further-
more, this infection has been reported in residents of, and
visitors returning from, endemic areas, mainly Portugal,
Spain, Cyprus and central Italy (Calisher et al., 1987; Eitrem
and Niklasson, 1990; Mendoza-Montero et al., 1998;
Schwarz et al., 1995). The infection is characterized by
aseptic meningitis, meningoencephalitis, or encephalitis
associated with symptoms such as fever, myalgia, severe
frontal headache, vomiting, ocular pain, and nucal rigidity
(Dionisio et al., 2001; Nicoletti et al., 1991, Valassina et al.,
1998a). Asymptomatic infections and infections without005) 66–73
Fig. 1. Surviving test. (U) Adult Balb/c mice ic. infected with 50 PFU of
TOSV (1812V) strain. (- - - -) mock-treated control mice ic. inoculated
with MEM, (—o—) mice sc. infected with 103 PFU of TOSV (1812V)
strain, (—*—) mock-treated control mice sc. inoculated with MEM. The
ic.-infected group showed a survival curve statistically different from the
mock-treated control mice ( P = 0.0001).
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1997). During epidemics, humans may act as a major host in
the vertebrate–insect–vertebrate cycle. Transstadial and
transovarial transmission probably serve as alternative
mechanisms of virus perpetuation (Endris et al., 1983; Tesh
and Modi, 1984). Little is known about the pathogenesis of
Toscana virus infection, due to the lack of a suitable animal
model. Field isolates of sand fly fever viruses have been
reported to be poorly infectious in laboratory animals and
unable to kill suckling mice even after intracerebral
injection (Tesh and Modi, 1984). We report a convenient
animal model for studying TOSV pathogenesis. We selected
a neuroadapted strain that is able to infect the CNS and to
induce apoptosis in the brain of intracerebrally inoculated
mice, leading to animal death. On the contrary, the same
strain induced a mild infection that was not accompanied by
evident clinical symptoms and that allowed subcutaneously
inoculated mice to survive.Results
TOSV causes a lethal infection in adult laboratory mice
In an attempt to develop an animal model for Toscana
virus, we studied the effects of different routes of virus
infection on morbidity and mortality in Balb/c mice. First,
we tried to adapt TOSV growing in mouse brain. The virus
suspension, obtained from a TOSV strain isolated from a
case of clinical meningitis and passaged in Vero cells, did
not produce any symptoms in newborn mice or in ic.- or sc.-
inoculated adult mice. However, the same strain was
adapted to replicate in adult mouse brain after two passages
in newborn mouse brain and serial passages in culture cells
(as described in detail in Materials and methods). Adult
Balb/c mice were ic. infected with TOSV (1812V), ranging
from 0.5 PFU to 10000 PFU in 10 Al. At 4–5 days
postinfection, ruffled fur, reduced spontaneous activity and
weight loss were observed. Afterwards, the animals were
obviously sick or moribund. The quickly progressing
disease led to the death of all animals within 10 days
(Fig. 1). These mice were used to determine a LD50 of
infection, of 10 PFU. However, mice infected by TOSV
(1812V) via the subcutaneous route, that mimics an
arthropod borne infection, did not develop evident clin-
ical–pathological symptoms.
Pathological findings and viral growth in mouse brain
Macroscopic findings consisted of softening of the
cerebral tissue and meningeal swelling of ic.-injected
mice, compared to sc.-treated mice and controls. In ic.-
injected mice, histological examination revealed wide-
spread degenerative phenomena and cell death in the gray
matter of deep nuclei and hippocampus (Fig. 2). Cerebral
cortical gray matter showed less severe and/or focaldamage involving the deep layers (IV, V, and VI) and,
in the cerebellar cortex, few Purkinje cells showed mild
degenerative phenomena. Various types of neurons (large
and smaller neurons, pyramidal neurons, Purkinje cells)
showed swollen and/or vacuolated cytoplasm and nuclear
chromatolysis. In addition, other neurons exhibited mor-
phological features of apoptosis (i.e., hypereosinophilic
cytoplasm, condensed chromatin, shrunken, and frag-
mented nucleus). Apoptotic bodies (i.e., fragments of
condensed nuclei surrounded by a rim of cytoplasm) were
also observed. There were some cytomegalic neurons. The
neuronal nature of damaged and apoptotic cells in gray
matter was confirmed by cytoplasmic positivity for
neuronal markers such as neural specific enolase (NSE),
neurofilaments, and synaptophysin, and negativity for the
Gliofibrillary Acid Protein (GFAP), that labels glial cells
(astrocytes and oligodendrocytes). White matter showed
mild spongiosis, but glial cells were undamaged and there
was no demyelination. Likewise, ependymal cells showed
degenerative phenomena being often detached from the
ventricular walls (Fig. 3). Interestingly, there were no
inflammatory infiltrates and in fact, neither granulocytes
nor lymphocytes were detected, as confirmed by morpho-
logical features of cellular tissue components and by their
negativity to the leukocyte marker leukocyte common
antigen (LCA), to the B-lymphocyte marker (anti-CD19)
and to the T lymphocyte marker (anti-CD3). Viral antigen
distribution was diffuse in the gray matter, especially in
deep nuclei and the hippocampus of ic.-injected mice,
while the white matter was negative (Fig. 3). In the
cerebral cortex, there were focal areas of positive cells,
mainly located in deep layers (IV, V, VI). There were
some antigen-positive Purkinje cells in the cerebellar
cortex. Various types of neurons (large and smaller
neurons, pyramidal cells, Purkinje cells) were antigen-
positive. Meningeal and ependymal cells were also
positive. In contrast, cerebellar granuli and glial cells
Fig. 2. Cerebral damage induced by TOSV in ic.-injected mice. Hematoxylin and eosin staining showing cytoplasmic vacuolization of neurons and spongiosis
of the white matter in treated mice compared to controls in different brain areas: hippocampus (a, control mice; b, treated mice; original magnification 400);
cerebral cortex (c, control mice; d, treated mice; 200); gray matter of a deep nucleus (e, control mice; a pyramidal neuron is indicated by arrow; f, treated
mice; 400). Apoptotic bodies (f, thin, long arrows), and an apoptotic cell (f, thick arrow) are shown. Immunohistochemistry shows a pyramidal neuron with
cytoplasmic positivity for neurofilaments and a shrunken, apoptotic nucleus with condensed chromatin (g; 400); the long arrow indicates an undamaged
nucleus of an oligodendrocyte, negative to neurofilaments. TUNEL-neurofilaments double staining of apoptotic pyramidal neurons (h, 1000).
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lapping of damaged neurons and TOSV-infected neurons
(Fig. 3). All the features described above were moreFig. 3. Virus immunohistochemistry of tissues drawn from mice inoculated with T
strong TOSV cytoplasmic positivity; astrocytes of the white matter (indicated by
positive apoptotic blackish nuclei in TOSV-positive neurons (short arrows) and
positive ependymal cells in ic.-treated mice (b, 400). Moderate positivity to TOS
cortex of sc.-treated mice (c, 200). Neither TUNEL-positive nuclei nor cytoplasm
A large TOSV-positive cell (in the spleen of ic.-treated mice) (e, 1000), identifi
indicates a negative lymphocyte (e). Viral antigen distribution in a lymph node of
specifically marked with the CD-205 antibody (h, 400). TOSV-negative spleenpronounced in mice in which the virus caused death and
to a lesser extent in animals sacrificed 6 days after ic.
injection.OSV (1812V) strain. Neurons in the gray matter of ic.-injected mice show a
the arrows), are negative; inset (TUNEL-TOSV double staining): TUNEL-
TUNEL-negative oligodendrocyte nuclei (long arrows) (a, 400). TOSV-
Vof meningeal cells (long arrows) and neurons (short arrow) in the cerebral
ic positivity to TOSV is observed in control mice (d, hippocampus, 400).
ed as macrophage by anti-CD14 antibody (f,  1000) is shown. The arrow
sc.-treated mice (g, 400) overlaps with the distribution of dendritic cells,
(i, 400) and lymph node (l, 400) of control mice.
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demonstrate brain pathological alterations and/or apoptoses.
In sc.-inoculated mice, sacrificed 6 days after infection, only
some meningeal cells and few neurons of the hippocampus
were positive for TOSV antigen, but these cells did not
reveal any sign of degenerative phenomena or apoptosis
(Fig 3). However, the same cells were negative for TOSV in
the brains of all mice that were sc. inoculated and sacrificed
at 15 days.
There was no brain damage, apoptoses nor TOSVantigen
positivity in the controls.
TUNEL reaction in infected mouse brain
Virus-infected and mock-infected mouse brains were
examined using the TUNEL reaction for further demon-
stration of apoptosis (Figs. 2, 3). Positive reaction was
revealed by a dark brown/blackish staining of nuclei. The
distribution of TUNEL-positive cells was similar to the
distribution of virus-antigen-positive cells in ic.-treated
mice, as identified by TUNEL and immunohistochemistry
for viral antigen and neurofilament double staining. We
were unable to detect TUNEL-positive cells in sc.-treated
mice or in the controls.
Apoptotic counts and statistics
The apoptotic index (AI) was significantly higher in the
gray matter of deep nuclei and hippocampus of dead mice
compared to those sacrificed on the 6th day (P b 0.0001;
P = 0.003, respectively). On the contrary, there were no
significant differences in the AI assessed in the gray matter
of cerebral and cerebellar cortex between the two groups
(P = 0.4; P = 0.7, respectively) (Table 1). In the group of
animals sacrificed on the 6th day, the AI was significantly
higher in the gray matter of deep nuclei compared to the
hippocampus or cerebellar cortex (P b 0.0001); in
hippocampus compared to cerebellar cortex (P = 0.002);
yet it was not statistically different in the hippocampus
compared to the cerebral cortex (P = 0.08) or in the
cerebral cortex compared to the cerebellar cortex (P =
0.12). In the group of animals killed by the virus, the AI
was significantly higher in the gray matter of deep nuclei
than in all other areas (P b 0.0001); in the hippocampus
compared to the cerebral and cerebellar cortex (P b
0.0001); and in the cerebral vs. cerebellar cortex (P =
0.008) (Table 1).Table 1
Mean values F standard error (SE) of apoptotic index (AI) in different brain are
TOSV-infected brain Deep nuclei Hippocam
Dead mice* 7 F 0.64 1.5 F 0.
Sacrificed mice** 3.68 F 0.51 0.82 F 0.
Values represent the mean AI F SE of 50 analyzed fields.
The brain was drawn from moribund mice sacrificed between the 7th and 10th dLocalization of TOSV in other organs of infected mice
Histological examination of the organ samples provided
further evidence of the infection of the animals, with the
most prominent lesions located in the brain. Macroscopic or
histological alterations were not evident in any other organ
examined either in ic.- and sc.-treated mice. However,
immunohistochemistry showed TOSVantigen-positive mac-
rophages and dendritic cells mainly located in the sub-
capsular area of the spleen and lymph nodes in all ic.-treated
mice and in sc.-injected animals sacrificed at 6 days (Fig. 3).
Lymphocytes were, however, negative. Immunohistochem-
istry performed on consecutive tissue sections further
confirmed the nature of infected cells (Fig. 3). We were
unable to demonstrate virus-induced apoptoses in TOSV-
positive cells by TUNEL-TOSV double staining. Neither
virus expression nor cell alterations were detected in the
control organs.
Viraemia and TOSV replication
TOSV RNA was detected by RT-PCR in the brain,
spleen, lymph nodes and blood of ic.- and sc.-infected mice,
sacrificed at 6 days (Figs. 4A, B). The TOSV RNA genome
was also detected in the spleen and blood, but to a lower
extent, in the sc.-infected mice sacrificed at 15 days (Fig.
4C). However, viral RNA was no longer present in the
brains of these mice. No viral RNA was detected in any
other organ. Signs of virus replication were detected
particularly in neurons. In fact, the virus titre was high
(1.4  107 PFU/ml) in the brain of ic.-infected mice,
considering that the animals had been challenged with 50
PFU of TOSV (1812V), and it was lower in the blood
(1.4  103 PFU/ml). The virus was also isolated on cell
cultures from the brain of sc.-infected mice sacrificed at 6
days, but at a very low titre (b5 PFU/ml). However, no virus
was isolated from the brain, spleen, and lymph nodes of the
same mice sacrificed at 15 days.
Protection of mice with inactivated TOSV
We performed protection experiments in order to provide
further proof that TOSV caused the lethal infection and
encephalitis in adult mice. Adult Balb/c mice were infected
ic. with 50 PFU of the neuroadapted strain of TOSV after
being inoculated ip. with inactivated TOSVas described. All
immunized animals developed a specific humoral responseas of ic.-treated mice
pus Cerebral cortex Cerebellar cortex
19 0.66 F 0.09 0.34 F 0.07
12 0.56 F 0.09 0.38 F 0.07
ay * and mice sacrificed on the 6th day post-infection **.
Fig. 4. RNA was isolated from different organs and RT-PCR followed by
nested PCR was performed on the TOSV N gene. The amplicons were
analyzed on 3% agarose gel and visualized with ethidium bromide. (A)
Organs drawn from a representative mouse ic. infected with TOSV and
sacrificed at 6 days; (B) organs drawn from a representative mouse sc.
infected with TOSV and sacrificed at 6 days; (C) organs drawn from a
representative mouse sc. infected with TOSV and sacrificed at 15 days; (D)
organs drawn from a representative mock-infected mouse. Lanes 1–6,
samples from spleen, lymph nodes, blood, brain, liver, lungs, respectively.
Lane 7, TOSV-positive control (309 bp); lane 8, negative PCR control for
RNA isolation (no template). GAPDH (glyceraldehyde-3-phosphate dehy-
drogenase): RT-PCR internal control of each sample.
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neutralizing antibody titre of 1/64 and all of them were
protected against the lethal challenge (Fig. 5). Only two
mice died a natural death at 1 month. This result supports
the notion that TOSV was the causative agent of the lethal
encephalitis in the animals.Fig. 5. Animal protection assay: (- - - -) Adult Balb/c mice previously
intraperitoneally inoculated with 106 PFU of inactivated TOSV or (—)
mock-treated control mice were intracerebrally infected with 50 PFU of
TOSV (1812V) strain.Discussion
Infection with TOSV induces a brain pathology like
meningitis or encephalitis in humans (Baldelli et al., 2004;
Dionisio et al., 2001; Valassina et al., 1998a, 1998b, 2000).
Up until now, no animal model has been available for
studying this viral infection. In our study, we developed a
mouse model for the characterization of viral pathogenesis
in various tissues. Neurons are the target cells in the central
nervous system (CNS) of infected mice, which succumb
after neuropathological changes become visible in the CNS.
The process of neuroadaption of TOSV in mice was crucial
for the emergence of TOSV variants with increased neuro-
virulence in mice. In fact, repeated passages of TOSV in
mouse brain allowed the selection of a highly neurovirulent
mutant. In this study, we have demonstrated that this
neuroadapted strain of TOSV is able to provoke brain cell
apoptosis after infection. Virus replication showed a
regional distribution, the gray matter of deep nuclei and
hippocampus being more susceptible to infection. Apoptoticcell death in TOSV ic.-infected mice occurred in the regions
of the brain that had high levels of virus replication. The
extensive brain tissue injury may be a consequence of virus-
triggered apoptosis in neurons that cannot regenerate (Lewis
et al., 1996; Ogata et al., 1991). The loss of nonrenewable
cells such as neurons may be especially critical in viral
pathogenesis (Despre`s et al., 1998; Lewis et al., 1996). Glial
cells were negative to TOSV infection. Histopathological
examination did not show perivascular cuffings of lympho-
cytes nor other inflammatory cells, suggesting that the
damage resulting from TOSV infection was not due to a host
anti-viral response. The lack of an inflammatory response is
characteristic of the apoptotic process in infected tissues,
and an absence or scarcity of local inflammatory cells has
also been observed in neuronal apoptosis induction by
alphaviruses and La Crosse virus (Lewis et al., 1996; Pekosz
et al., 1996). The absence of apoptotic neurons in sc.-
inoculated mice, in which we demonstrated TOSV positivity
only in some meningeal cells and few neurons of the
hippocampus and prehippocampal cortex, could be due to
the very low titre of TOSV (b5 PFU/ml) detected in the
animal brain and/or to a lesser possibility of detecting
apoptoses among a low number of infected cells. Further-
more, differences in virus localization and the incidence of
apoptosis in the different regions of the brain may be due to
a different susceptibility of neurons to infection/death. The
hippocampus is known to be particularly vulnerable to
injury and apoptotic cell death (Heron et al., 1993). The
presence of TOSV-positive ependymal cells was accompa-
nied by degenerative phenomena and cell detachment from
the ventricular walls that could partly contribute to the
altered liquor resorption/production and brain damage.
Macrophages in the spleen and lymph nodes of ic.-treated
mice were also TOSV-positive, and detection of viral RNA
in these samples confirmed these data, suggesting a possible
route for virus spreading via mononuclear cells. Viral
antigens were also detected in macrophages and dendritic
M. Grazia Cusi et al. / Virology 333 (2005) 66–73 71cells of the spleen and lymph nodes in addition to some
meningeal cells and neurons in the brain of sc.-injected mice
at day 6 post-infection. Although subcutaneously infected
mice brain cells were virus negative at 15 days post-
infection, there was a presence of TOSV RNA in spleen
cells as confirmed by RT-PCR. However, since the virus was
not isolated in these samples, it is also possible that the live
virus was no longer viable in these animals, all of which
survived viral challenge. Thus, we can hypothesize that
natural infection might be due to a secondary involvement of
brain after lymphoid organ infection in humans. In fact, the
animal model of TOSV subcutaneous infection could reflect
the clinical picture occurring in humans, showing that the
virus has a marked neurotropism after a first spread in the
lymphoid organs. A subsequent virus clearance occurs in
these mice by immune mechanisms, which are still
unknown, allowing animals to survive. This investigation
demonstrated a strong correlation among clinical symptoms,
histological findings and the cause of death with, in fact, ic.-
infected animals dying of acute encephalitis. The protection
test performed on mice previously inoculated with inacti-
vated virus further confirmed the role of TOSV in the
etiopathogenesis of the neurological disease. For this reason,
this animal model should be helpful in the development of
therapeutic and, most of all, prophylactic measures against
Toscana virus infection.Materials and methods
Virus and cells
A TOSV strain (1812) isolated from the cerebrospinal
fluid (CFS) of a patient with meningitis was used for all
infections. The virus was passaged twice in Vero cells
(ATCC CCL-81), and once in McCoy cells (ATCC CRL-
1696), then titrated. 103 PFU of the virus was inoculated in
the brain of newborn mice (Balb/c, Charles River, Milan,
Italy). After 1 week, the mice were sacrificed and the brain
homogenate was inoculated intracerebrally (ic.) in newborn
mice. The brain collected from these deceased mice was
homogenized on ice by douching in Minimum Essential
Medium (MEM) (Life Technologies, Milan, Italy) supple-
mented with 2% fetal bovine serum (Life Technologies) and
clarified by centrifugation at 4 8C for 20 min at 2000  g.
103 PFU of this virus was used to ic. infect adult mice which
then died at 7 days. The brain was drawn and homogenized
to infect Vero cells. The stock virus had a titre of 1.2  106
PFU/ml and it was used as TOSV strain (1812 V) for
neurovirulence tests in adult mice.
Animal infection and preparation of samples
Each experiment was repeated three times to ensure the
reproducibility of results and each group of animals was
composed of ten (20 in group B1) 4-week-old femaleBALB/c mice (Charles River, Milan, Italy. Groups A1–A2
were ic. infected (50 PFU), and groups B1–B2 were
subcutaneously (sc.) infected (105 PFU) with TOSV
(1812V) strain, then examined daily for clinical symptoms.
Eagle’s essential medium (MEM) (Life Technologies) was
injected ic. (group C) or sc. (group D) in the control groups.
Groups A2 and B2 were sacrificed on the 6th day. Ten mice
in group B1 were sacrificed on the 15th day for sample
analysis and those remaining were left alive for the
surviving test. At the 7th–10th day, ic.-infected animals
(group A1) were dead or moribund. Moribund animals were
killed and organs (brain, lungs, liver, spleen, lymph nodes,
and blood) were sampled for further analysis. Control and
sc.-injected mice did not manifest clinical symptoms.
Autopsies were performed on all animals.
Plaque reduction assay
Serum samples were diluted from 1/2 to 1/160 in doubling
dilutions in MEM (Life Technologies). Equal volumes of
each serum dilution and TOSV (100 PFU) were mixed and
incubated at 37 8C for 90 min, then at 4 8C for 30 min. 200 Al
of the mixture was used to inoculate a confluent layer of Vero
cells in a 6-well plate that was incubated at 37 8C in 5% CO2
for 1 h. The medium was then removed and 2.5 ml of overlay
medium containing 3% purified agar (Oxoid, Milan, Italy)
was added. After 5 days, the cell sheet was stained with
neutral red. Plaques were counted and the neutralization end
point was calculated at the dilution that would produce a 50%
reduction in plaque formation compared to the virus control.
Titration for infectious virus content
Groups A2 and B2 were sacrificed at 6 days and brain,
spleen, lymph nodes, and blood were analyzed. Tissue
homogenates were prepared in MEM (Life Technologies)
supplemented with 2% FCS. These samples were then
diluted to be titrated by plaque assay on a 6-well plate of
Vero cells and incubated at 37 8C for 5 days as described
above. The viral titre was determined as PFU/ml.
Animal protection experiments
One group (group E) of adult mice was immunized with
two consecutive ip. injections of UV inactivated TOSV (105
PFU), administered 3 weeks apart and a control group
(group F) was administered with MEM (Life Technologies).
TOSV antibody titers were determined by using an ELISA
test (Valassina et al., 1998b) and the plaque reduction assay.
Twenty days after the last immunization, these mice (groups
E and F) were ic. challenged with 10 LD50 (50 PFU) of
TOSV (1812V) and monitored for clinical symptoms, and
survivors were observed for 2 months. Survival curves were
constructed using the Kaplan and Meier method (Kaplan
and Meier, 1958). Comparisons within groups reflects a
two-tailed analysis.
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Brain, liver, lung, blood, spleen, and lymph nodes of
infected mice were subjected to RNA extraction by using a
Total RNA isolation kit (Promega, Mannheim, Germany).
Total RNA was amplified by RT-PCR; the reaction was
performed at 37 8C for 30 s, followed by 35 cycles (94 8C for
1 min, 52 8C for 30 s and 72 8C for 40 s). Sequences of the
primers used to amplify a 465 bp fragment of TOSV N gene
were forward primer 5V GGTGAAGAATCGTCCACTCA 3V
(nt 1184–1203) and reverse primer 5V CCAGAGGCCAT-
GATGAAGAAGAT 3V (nt 1593–1615). The amplified
product was then subjected to a nested PCR using the primers
forward 5V TTGTTCTCAGAGATGGATTTATG 3V (nt
1255–1277) and reverse 5V AACCTGATTTCAGTCTAC-
CAGTT 3V (nt 1542–1564) for 40 amplification cycles (94 8C
for 30 s, 58 8C for 30 s and 72 8C for 40 sec) to provide a 309-
bp fragment. The products were subsequently gel purified
and sequenced for confirmation. GAPDH (glyceraldehyde-3-
phosphate dehydrogenase) served as an internal control
and was amplified by using GAPDH forward primer
5VTTCACCACCATGGAGAAGGC3V and GAPDH reverse
primer 5VGGCATGGACTGTGGTCATGA3V (Amplicon
length of 236 bp). The TOSV genome was used as a
positive control for RT-PCR.
Histological and immunohistochemical analysis
After removal, organs were post-fixed in phosphate-
buffered 10% formalin. After fixation, fragments of liver,
spleen, lymph nodes, lungs, and coronal slices of brain were
embedded in paraffin. Serial sections from each organ slice
were partly stained with hematoxylin and eosin (HE),
thionin, Bielschowski and luxol fast blue (Klqver-Barrera)
and partly processed for immunohistochemistry and
TUNEL reactions. A commercial kit (Super Sensitive
Bioptica, Milan, Italy) was used to perform immunohisto-
chemistry in order to detect virus antigen distribution and to
identify the infected cell types. After deparaffinization,
sections were washed in Tris–HCl buffer (pH 7.6) and
incubated for 8 min with UltraV Block. After washing, the
following mAb were applied for 1 h: anti-N TOSV protein
(DIESSE srl Siena, Italy; diluted 1:400); -NSE ( Dako
Cytomation S.P.A., Milan, Italy); -Neurofilaments (Dako);
-synaptophysin (Dako); -GFAP (Dako), -LCA (Dako);
-CD19 (BD Biosciences, San Diego, CA, USA); -CD3 (BD
Biosciences); -CD 14 (BD Biosciences); - CD205 (Cymbus
Biotechnology Ltd., Chandlers Ford, UK). All the immune
reagents were diluted as recommended by the manufacturer.
After washing, the secondary biotinylated goat anti-mouse
antibody (NeoMarkers, BioOptica, Milan, Italy) was
applied for 20 min at room temperature. Sections were
washed again and then incubated for 20 min with
Streptavidin Alk-Phos or streptavidin-HRP (NeoMarkers)
at room temperature. Conjugates were visualized with red
or brown staining using either new fuchsin (Dako) ordiaminobenzidine solution (NeoMarkers) as chromogens,
after 8 min incubation, respectively. Counterstaining was
done with hematoxylin.
TUNEL reaction
Deparaffinized sections were incubated with proteinase
K (Roche Diagnostics, Milan, Italy) for 15 min at room
temperature, then with TdT buffer and biotinylated dUTP
for 1 h at 37 8C in a humidified chamber. Reaction was then
stopped after incubation in SSC for 15 min at room
temperature. After washing in TBS, sections were incubated
with Streptavidin-AP-Conjugate (Roche) and diluted 1:
5000 in buffer for 30 min at room temperature in a
humidified chamber. Chromogen reaction was developed
with BCP/NBT Substrate System (Dako) for 5 min. Fuchsin
and hematoxylin were used for cytoplasmic and nuclear
counterstaining, respectively. TUNEL-positive nuclei were
stained dark brown/blackish; TUNEL-negative nuclei were
stained blue. For TUNEL-neurofilaments/TOSV double
staining, after processing with TUNEL, sections were
washed, saturated with goat serum for 20 min and then
incubated with anti-neurofilaments mAb and anti-TOSV N
protein mAb for 1 h, as described above.
Apoptotic counts
In order to compare neuronal apoptotic death among the
different groups and gray matter areas, apoptoses were
quantified, by assessing the apoptotic index (AI). Apoptoses
and apoptotic bodies were counted, as previously described
(Miracco et al., 1993), in 50 randomly chosen high power
fields (400) in TUNEL-stained sections and counts were
reported as the mean number F SE per field. Counts were
made in the gray matter of distinct areas (deep nuclei,
hippocampus, cerebral and cerebellar cortex). Results were
statistically analyzed and the significance of differences
between the two groups (mice sacrificed at the 6th day, and
moribund mice sacrificed at the 7th–10th day) and between
the distinct cerebral areas in each group were examined using
the Kruskal–Wallis one-way analysis of variance. We con-
sidered P values equal to or smaller than 0.05 as significant.Acknowledgment
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